[1]
2020. Serum patterns of mir-23a and mir-181b in irritable bowel syndrome and colorectal cancer - A pilot study. Biomolecules and Biomedicine. 20, 2 (May 2020), 254–261. DOI:https://doi.org/10.17305/bjbms.2019.4392.